<table id="table8" width="85%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 8	Established and Other Potentially Significant Drug Interactions With Ganciclovir</caption>
<col align="left" valign="top" width="28%"></col>
<col align="left" valign="top" width="41%"></col>
<col align="left" valign="top" width="31%"></col>
<thead>
<tr>
<th align="center" stylecode="Lrule Rrule">Name of the Concomitant Drug</th>
<th align="center" stylecode="Rrule">Change in the Concentration of Ganciclovir or Concomitant Drug</th>
<th align="center" stylecode="Rrule">Clinical Comment</th>
</tr>
</thead>
<tbody>
<tr>
<td stylecode="Lrule Rrule toprule">Zidovudine</td>
<td stylecode="Rrule toprule">↓ Ganciclovir<br/>↑ Zidovudine</td>
<td stylecode="Rrule toprule">Zidovudine and Valcyte each have the potential to cause neutropenia and anemia </td>
</tr>
<tr>
<td stylecode="Lrule Rrule toprule">Probenecid</td>
<td stylecode="Rrule toprule">↑ Ganciclovir</td>
<td stylecode="Rrule toprule">Patients taking probenecid and Valcyte should be monitored for evidence of ganciclovir toxicity</td>
</tr>
<tr>
<td stylecode="Lrule Rrule toprule">Mycophenolate Mofetil (MMF)</td>
<td stylecode="Rrule toprule">↔ Ganciclovir (in patients with normal renal function)<br/>↔ MMF (in patients with normal renal function)</td>
<td stylecode="Rrule toprule">Patients with renal impairment should be monitored carefully as levels of MMF metabolites and ganciclovir may increase</td>
</tr>
<tr>
<td stylecode="Lrule Rrule toprule">Didanosine</td>
<td stylecode="Rrule toprule">↓ Ganciclovir<br/>↑ Didanosine</td>
<td rowspan="2" stylecode="Rrule toprule">Patients should be closely monitored for didanosine toxicity</td>
</tr>
</tbody>
</table>